BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3545105)

  • 1. Characterisation of nucleolar proteins as autoantigens using human autoimmune sera.
    Pfeifle J; Anderer FA; Franke M
    Ann Rheum Dis; 1986 Dec; 45(12):978-86. PubMed ID: 3545105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma).
    Reimer G; Steen VD; Penning CA; Medsger TA; Tan EM
    Arthritis Rheum; 1988 Apr; 31(4):525-32. PubMed ID: 2451921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against a novel nucleolar and cytoplasmic antigen (p105-p42) present in the sera of patients with a subset of rheumatoid arthritis (RA) with signs of scleroderma.
    Labrador M; Algueró A; Díaz C; Geli C; Pérez E; García-Valero J; Rodriguez-Sanchez JL; Gelpí C
    Clin Exp Immunol; 1998 Nov; 114(2):301-10. PubMed ID: 9822291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera.
    Ochs RL; Lischwe MA; Spohn WH; Busch H
    Biol Cell; 1985; 54(2):123-33. PubMed ID: 2933102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 6. Antinuclear antibodies detected by indirect immunofluorescence on HEp2 cells and by immunoblotting in patients with systemic sclerosis.
    Briolay J; Gioud M; Monier JC; Rodde JL; Cohen J; Roux B; Kaliss B
    Autoimmunity; 1989; 2(2):165-76. PubMed ID: 2491600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical significance of antibodies to SM, RNP and SSR polypeptides detected by immunoblotting technique].
    Xu YH; Chen SL; Ye P
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):472-5, 510. PubMed ID: 2086016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein components reactive with anti-PM/Scl autoantibodies.
    Gelpi C; Algueró A; Angeles Martinez M; Vidal S; Juarez C; Rodriguez-Sanchez JL
    Clin Exp Immunol; 1990 Jul; 81(1):59-64. PubMed ID: 2199097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
    Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
    Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies.
    Li XZ; McNeilage LJ; Whittingham S
    Arthritis Rheum; 1989 Sep; 32(9):1165-9. PubMed ID: 2789047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
    Bernstein RM; Steigerwald JC; Tan EM
    Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidden anti-nuclear antibodies in rheumatic diseases.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1980 Feb; 39(2):538-43. PubMed ID: 6993073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.
    Tan EM; Rodnan GP; Garcia I; Moroi Y; Fritzler MJ; Peebles C
    Arthritis Rheum; 1980 Jun; 23(6):617-25. PubMed ID: 6155920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear matrix antibody. Hidden antinuclear antibody in patients with connective tissue diseases.
    Deng JS; Fratto J; Elenitsas R
    Am J Clin Pathol; 1990 Nov; 94(5):606-12. PubMed ID: 2239824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.